4th Quarter - Report

THE NICKLES GROUP, LLC for GILEAD SCIENCES, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Monitored issues related to the reimbursement of CAR-T cell therapy. Monitored H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, the Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act, as they relate to drug pricing. Monitored H.R. 3684, The Infrastructure Investment and Jobs Act, as it relates to sequestration and drug pricing.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 19 (117th), S. 2164 (117th), H.R. 3 (117th), H.R. 3684 (117th), H.R. 5376 (117th)

Government Issues GOV

Monitored issues related to the reimbursement of CAR-T cell therapy. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, the Build Back Better Act, and H.R. 19, the Lower Costs, More Cures Act, as they relate to drug pricing. Monitored H.R. 3684 (P.L. 117-58), The Infrastructure Investment and Jobs Act, as it relates to sequestration and drug pricing.

LobbyistCovered position, as disclosed
BRETT BAKER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3 (117th), H.R. 5376 (117th), H.R. 19 (117th), H.R. 3684 (117th)

Budget/Appropriations BUD

Monitored S.Con.Res.14, FY 2022 Budget Resolution.

LobbyistCovered position, as disclosed
GREG D'ANGELO —
MARY BETH SAVARY TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 14 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.